Literature DB >> 22833081

Low-grade serous neoplasms of the ovary with transformation to high-grade carcinomas: a report of 3 cases.

Karuna Garg1, Kay J Park, Robert A Soslow.   

Abstract

Ovarian borderline tumors usually occur in young patients and are associated with good clinical outcomes. A proportion of these tumors, particularly those with micropapillary features, may progress to low-grade serous carcinomas. Evolution of low-grade serous neoplasms to high-grade carcinomas is rare and infrequently reported. In this case report, we describe 3 cases of serous borderline tumor that progressed to high-grade carcinoma. Patient ages were 22, 35, and 47 yr. Two patients were initially diagnosed with ovarian serous borderline tumor, and recurred in the pelvis 3 and 10 yr later with sarcomatoid carcinoma. The third patient presented with low-grade serous carcinoma arising in a micropapillary serous borderline tumor, and recurred with a carcinosarcoma 3 yr later. All 3 patients had an aggressive clinical course: 2 died of disease and 1 patient has disease progression on chemotherapy. Occasional low-grade serous tumors of the ovary may transform to high-grade carcinomas, which can occur many years after initial diagnosis. The presence of a high-grade component significantly worsens patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22833081      PMCID: PMC4849135          DOI: 10.1097/PGP.0b013e31824ae6f2

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  17 in total

1.  Sarcomatoid carcinoma arising within a serous borderline ovarian tumour: a case report and practical approach to differential diagnosis.

Authors:  T D Andrews; P M Dutton; G Beattie; A Al-Nafussi
Journal:  Histopathology       Date:  2007-09-28       Impact factor: 5.087

2.  The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

3.  Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

Authors:  Y Shimizu; S Kamoi; S Amada; F Akiyama; S G Silverberg
Journal:  Cancer       Date:  1998-03-01       Impact factor: 6.860

4.  Sarcoma-like nodules in cystic ovarian tumours.

Authors:  J McCullough; P Batman; D Parker
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

5.  Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis.

Authors:  Anna Yemelyanova; Russell Vang; Malti Kshirsagar; Dan Lu; Morgan A Marks; Ie Ming Shih; Robert J Kurman
Journal:  Mod Pathol       Date:  2011-05-06       Impact factor: 7.842

Review 6.  Malign mural nodules associated with serous ovarian tumor of borderline malignancy: a case report and literature review.

Authors:  Tayfun Gungor; S Ozlem Altinkaya; Serap Akbay; Umit Bilge; Leyla Mollamahmutoglu
Journal:  Arch Gynecol Obstet       Date:  2009-07-14       Impact factor: 2.344

Review 7.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

8.  High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23-year-old woman.

Authors:  M Ruhul Quddus; Lanita B Rashid; Katrine Hansen; C James Sung; W Dwayne Lawrence
Journal:  Histopathology       Date:  2009-05       Impact factor: 5.087

9.  Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.

Authors:  Claudia Provenza; Robert H Young; Jaime Prat
Journal:  Am J Surg Pathol       Date:  2008-03       Impact factor: 6.394

10.  Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases.

Authors:  Robin L Parker; Philip B Clement; David J Chercover; Thangaraja Sornarajah; C Blake Gilks
Journal:  Int J Gynecol Pathol       Date:  2004-07       Impact factor: 2.762

View more
  9 in total

1.  Coexistence of BRAF V600E and TERT Promoter Mutations in Low-grade Serous Carcinoma of Ovary Recurring as Carcinosarcoma in a Lymph Node: Report of a Case.

Authors:  Mahkam Tavallaee; David F Steiner; James L Zehnder; Ann K Folkins; Amer K Karam
Journal:  Int J Gynecol Pathol       Date:  2019-07       Impact factor: 2.762

2.  Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa.

Authors:  Rajmohan Murali; Pier Selenica; David N Brown; R Keira Cheetham; Raghu Chandramohan; Nidia L Claros; Nancy Bouvier; Donavan T Cheng; Robert A Soslow; Britta Weigelt; W Glenn McCluggage
Journal:  Histopathology       Date:  2019-01-15       Impact factor: 5.087

3.  Clinicopathologic and Molecular Features of Paired Cases of Metachronous Ovarian Serous Borderline Tumor and Subsequent Serous Carcinoma.

Authors:  Michael Herman Chui; Deyin Xing; Felix Zeppernick; Zoe Q Wang; Charlotte G Hannibal; Kirsten Frederiksen; Susanne K Kjaer; Leslie Cope; Robert J Kurman; Ie-Ming Shih; Tian-Li Wang; Russell Vang
Journal:  Am J Surg Pathol       Date:  2019-11       Impact factor: 6.394

4.  Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.

Authors:  Russell Vang; Douglas A Levine; Robert A Soslow; Charles Zaloudek; Ie-Ming Shih; Robert J Kurman
Journal:  Int J Gynecol Pathol       Date:  2016-01       Impact factor: 2.762

5.  Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.

Authors:  Elizabeth Morency; Mario M Leitao; Robert A Soslow
Journal:  Int J Gynecol Pathol       Date:  2016-05       Impact factor: 2.762

6.  Trametinib response in heavily pretreated high-grade ovarian cancer: One step towards precision medicine.

Authors:  Serena Cappuccio; Maria Grazia Distefano; Viola Ghizzoni; Anna Fagotti; Giovanni Scambia
Journal:  Gynecol Oncol Rep       Date:  2020-02-13

7.  The poor prognosis of sarcomatoid carcinoma arising from low grade serous ovarian cancer: A case report and review of the literature.

Authors:  Paulina Haight; Johanna Savage; Kristin Bixel
Journal:  Gynecol Oncol Rep       Date:  2021-02-23

Review 8.  The Many Faces of Serous Neoplasms and Related Lesions of the Female Pelvis: A Review.

Authors:  Sameera Rashid; Maria A Arafah; Mohammed Akhtar
Journal:  Adv Anat Pathol       Date:  2022-05-01       Impact factor: 3.875

9.  Ovarian carcinoma in situ of presumable fallopian tube origin in a patient with Lynch syndrome: A case report.

Authors:  Kayo Inoue; Hiroshi Tsubamoto; Hiroyuki Hao; Kazuo Tamura; Tomoko Hashimoto-Tamaoki
Journal:  Gynecol Oncol Case Rep       Date:  2013-05-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.